XML 109 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Interest expense $ (240.7) $ (244.2) $ (235.1)
Operating income 1,330.2 1,325.7 1,305.2
Revenues 11,554.8 11,333.4 10,308.0
Cost of Revenue 8,302.3 8,157.0 7,216.2
Gross profit 3,252.5 3,176.4 3,091.8
Selling, general and administrative expenses 1,624.5 1,570.9 1,499.2
Amortization of intangibles and other assets 243.2 231.7 216.5
Restructuring and other special charges 54.6 48.1 70.9
Equity method income, net 9.8 11.6 11.3
Investment income 8.8 7.5 2.1
Other, net (3.2) 167.7 (6.0)
Earnings before income taxes 1,104.9 1,268.3 1,077.5
Net earnings 824.9 883.9 1,232.9
Less: Net earnings attributable to the noncontrolling interest 1.1 0.2 5.8
Net earnings attributable to Laboratory Corporation of America Holdings 823.8 883.7 1,227.1
Income Tax Expense (Benefit) $ 280.0 $ 384.4 $ (155.4)